ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,429Medicare Part D Prescriptions Filled, Including Refills

Rank: 304 out of 972

$476K Total Retail Price of All Prescriptions

Rank: 345 out of 972

210 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 210 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 8,907 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 313 301 1 2
AMLODIPINE BESYLATE 307 301 2 4
FUROSEMIDE 284 266 3 7
LISINOPRIL 270 270 4 1
POTASSIUM CHLORIDE 261 236 5 13
DONEPEZIL HCL 236 236 6 26
CARVEDILOL 227 213 7 21
NAMENDA 222 222 8 38
OMEPRAZOLE 220 212 9 5
TRAMADOL HCL 197 182 10 15
LEVOTHYROXINE SODIUM 182 176 11 3
ATORVASTATIN CALCIUM 176 158 12 11
QUETIAPINE FUMARATE 171 171 13 83
HYDROCODONE-ACETAMINOPHEN 169 149 S3 14 6
METOPROLOL TARTRATE 165 158 15 9
GLIMEPIRIDE 159 144 16 34
EXELON 121 121 17 125
WARFARIN SODIUM 117 117 18 12
METOPROLOL SUCCINATE 113 113 19 16
SPIRONOLACTONE 112 112 20 54
MIRTAZAPINE 105 102 21 46
LIPITOR 104 98 22 90
SERTRALINE HCL 102 102 23 25
SEROQUEL 94 94 24 164
TRAZODONE HCL 92 92 25 35
JANTOVEN 92 92 25 160
RISPERIDONE 92 92 25 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 85 28 32
ALBUTEROL SULFATE 90 79 29 169
PLAVIX 86 86 30 55
CITALOPRAM HBR 79 77 31 19
PANTOPRAZOLE SODIUM 79 79 31 41
DIGOXIN 78 78 33 52
ESCITALOPRAM OXALATE 75 75 34 65
LANTUS 73 73 35 44
COUMADIN 72 49 36 196
HYDROCHLOROTHIAZIDE 68 67 37 10
MEGESTROL ACETATE 67 67 R 38 195
METFORMIN HCL 66 62 39 8
IPRATROPIUM-ALBUTEROL 66 66 39 132
RANITIDINE HCL 66 60 39 24
AMOX TR-POTASSIUM CLAVULANATE 66 57 39 157
DIVALPROEX SODIUM 66 64 39 96
ATENOLOL 63 62 44 18
DIOVAN HCT 63 51 44 122
BUSPIRONE HCL 63 52 44 105
LOSARTAN POTASSIUM 61 61 47 17
DIOVAN 61 61 47 48
PRAVASTATIN SODIUM 61 61 47 20
CLOPIDOGREL 59 59 50 37
OXCARBAZEPINE 59 49 50 244
TRAMADOL HCL-ACETAMINOPHEN 57 57 52 155
LEXAPRO 57 57 52 177
AMLODIPINE BESYLATE-BENAZEPRIL 56 52 54 114
CLONIDINE HCL 55 55 55 57
ALLOPURINOL 53 53 56 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.